Home General Biotechnology Drug Patent Expirations in March 2012

Drug Patent Expirations in March 2012

Drug Patent Expirations in March 2012

*Drugs may be covered by multiple patents

TradenameApplicantGeneric NamePatent NumberPatent Expiration
GEODONPfizerziprasidone mesylate4,831,031Mar 2, 2012
GEODONPfizer Incziprasidone hydrochloride4,831,031Mar 2, 2012
GEODONPfizerziprasidone hydrochloride4,831,031Mar 2, 2012
ZOFRANGlaxosmithklineondansetron hydrochloride5,344,658*PEDMar 6, 2012
GENESAGensia Automedicsarbutamine hydrochloride5,395,970Mar 7, 2012
NUTROPIN DEPOTGenentechsomatropin recombinant5,912,015Mar 12, 2012
LEXAPROForest Labsescitalopram oxalateRE34712*PEDMar 14, 2012
AVANDIASb Pharmcorosiglitazone maleate5,002,953*PEDMar 17, 2012
AVANDAMETSb Pharmcometformin hydrochloride; rosiglitazone maleate5,002,953*PEDMar 17, 2012
AVANDARYLSb Pharmcoglimepiride; rosiglitazone maleate5,002,953*PEDMar 17, 2012
BONIVARocheibandronate sodium4,927,814Mar 17, 2012
ERAXISVicuronanidulafungin6,384,013Mar 19, 2012
ERAXISVicuronanidulafungin6,743,777Mar 19, 2012
VALTURNANovartisaliskiren hemifumarate; valsartan5,399,578Mar 21, 2012
GABITRILCephalontiagabine hydrochloride5,354,760Mar 24, 2012
SEROQUELAstrazenecaquetiapine fumarate4,879,288*PEDMar 26, 2012
SEROQUEL XRAstrazenecaquetiapine fumarate4,879,288*PEDMar 26, 2012
NUEDEXTAAvanir Pharmsdextromethorphan hydrobromide; quinidine sulfate5,206,248Mar 27, 2012
FLOXIN OTICDaiichiofloxacin5,401,741Mar 27, 2012
AVALIDESanofi Aventishydrochlorothiazide; irbesartan5,270,317*PEDMar 30, 2012
AVAPROSanofi Aventis Usirbesartan5,270,317*PEDMar 30, 2012

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.

Courtesy of DrugPatentWatch.com

NO COMMENTS

Leave a Reply